The Latest Breaking News from FDA

The decades-old surgical drug ketamine has found a new use — as an alternative to opioids for patients with chronic pain

Cathie Wood's flagship Ark Innovation ETF ARKK just had its best week ever thanks to Roku, DraftKings, Palantir and other huge winners on big news.

A new report shows fewer high school students are vaping. About 10% said they used electronic cigarettes in the previous month, down from 14% last year.

But Biden still wants to ban menthols to protect kids.

A new government report shows fewer high school students are vaping

Brazil now has one of the largest cigarette markets in the world, despite its efforts to rid the country of cigarettes through prohibition.

Movano Evie Ring reveals a launch date for its smart ring, which has been designed specifically for women.

Drugmaker Eli Lilly and Company (LLY) is scheduled to release its third-quarter results soon. While its revenue is expected to rise sharply over the prior-year quarter, its earnings are expected to decline. So, how should investors position themselves before the results are out? Read on to learn more….

The FDA appears likely to approve Crispr's gene-editing approach to sickle cell disease, analysts said Wednesday as CRSP stock gapped higher.